Our Curious Amalgam

Toggle navigation
  • About
  • Hosts
  • Gallery
  • Episodes
  • ABA
  • Search

#47 Sequences & Sparks: Life Sciences Innovation Mergers

https://ourcuriousamalgam.com/episode-player/1153/47-sequences-sparks-life-sciences-innovation-mergers.mp3

Recent economic research has examined potential killer acquisitions in the U.S., and regulators here and abroad have expressed competition concerns about acquisitions of startups. But innovation is a difficult and uncertain process. This panel explores hot topics, patent thickets, biologics, and the revamped UK CMA approach in a broader discussion of the renaissance of innovation theories of harm.

SESSION CHAIR / MODERATOR / SPEAKER

E. Bill BATCHELOR / Skadden Arps Slate Meagher & Flom LLP, Brussels

SPEAKERS

  • Deborah FEINSTEIN / Arnold & Porter, Washington, DC
  • W. Robert MAJURE / Cornerstone Research, Washington, DC
  • James R. WEISS / Deputy Assistant Director, Mergers I, Federal Trade Commission, Washington, DC

Presented by the Health Care & Pharmaceuticals Committee


Posted On May 1, 2020

Posted By Our Curious Amalgam

Posted In Health Care & Pharmaceuticals INDUSTRIES

Share


Prev

#46 Antitrust, IP & Trade Wars

Next

#48 How Do You Get to The Final Yes? The Art and Science of Settling Antitrust Class Actions

Scroll to the top

Don't miss new episodes every Monday. Subscribe now!

Our Curious Amalgam explores topics in antitrust, competition, consumer protection, data protection, and privacy law around the world with leading experts in those areas. It is an amalgam because it is a group of diverse topics all in one place. It is curious because it gets the experts and asks them in-depth questions.

© 2019-2023 American Bar Association. All Rights Reserved.

NEWS AND EVENTS
What's Going on at the Antitrust Law Section

CONTACT US
podcast@ourcuriousamalgam.com

Find us on social!

Facebook Twitter Instagram LinkedIn RSS Feed

Subscribe
Subscribe on iTunes
Listen on Google Podcasts
Listen to Stitcher
Listen on Spotify
Amazon music
The opinions expressed by the participants in the podcasts are their own and do not necessarily represent those of their employers or other affiliated organizations.